




版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、An Inactivated Enterovirus 71 Vaccinein Healthy Children文獻簡要介紹手足口病: ?手足口病:多發生于5歲以下兒童,表現口痛、厭食、低 熱、手、足、口腔等部位出現小皰疹或小潰瘍。多數患兒一周自愈。病原體:coxsackievirus A16(Cox A16) enterovirus 71(EV 71)并發癥: 神經系統并發;無細菌性腦膜炎 呼吸系統并發:肺水腫 循環系統并發:心肌炎檢查:咽拭子或糞便標本PCR、測序鑒定病毒臨床相似病:單純皰疹性口炎:由單純皰疹病毒引起,但沒有手、足部皰疹疹。 皰疹性咽頰炎:主要由柯薩奇病毒引起,病變在口腔后
2、部; 疫苗研究:時間:2012年3月2013年2月地點:廣西 七個縣人物:12000名 6至71月年齡段嬰兒實驗設計: 1、全體分為vaccine group/placebo group,接種兩次,觀察11個月,統計出現不良反應數量。 2、挑選亞組評估vaccine immunogenicity初次注射后第56天和180天是否出現EV71抗體。實驗結果:EV71:155例coxA16:102例嚴重病例:2例死亡:2例疫苗免疫效率:intention-to-treatment analysis: 97.4%per-protocal analysis:97.3%對coxA16無效。結論:疫苗對EV
3、71免疫效果顯著臨床試驗中的醫學詞匯李思奕 201201038phase clinical trial healthy vonlunteer, exploration of pharmacokinetics, bioavailability, toxicityphase clinical trial preliminary evaluation of efficacy and safetyphase clinical trial further assessment of benefit and hazard, promoting approval and marketing, large s
4、ample capacity-phase clinical trial monitoring efficacy and adverse events after entering the market, more indication(適應癥) seroconversion 血清轉化,血清陽轉:機體的免疫系統在受到抗原刺激后會產生抗體,將血清中無法檢測到抗體至剛好能夠檢測到抗體的這個點定義為血清轉換點。immunogenicity 免疫原性:是指能夠刺激機體形成特異抗體或致敏淋巴細胞的能力。即指抗原能刺激特定的免疫細胞,使免疫細胞活化、增殖、分化,最終產生免疫效應物質抗體和致敏淋巴細胞的特性。
5、titer 滴度:仍能產生陽性結果的最大稀釋度( titrate )。papular&vesicular rush 丘疹&皰疹。 herpes皰疹,皰疹病毒科病毒所致疾病febrile 發熱的,febrile infectious diseasenausea 惡心,反胃;SYN sicchasiaanorexia 厭食,食欲不振;orexiairritability 易怒; 應激性drowsiness 嗜睡;SYN somnolence 統計學詞匯介紹林 敏201201024“Over the course of two epidemic seasons, the vaccine effica
6、cy was 97.4% (95% confidence interval CI, 92.9 to 99.0) according to the intention-to-treat analysis and 97.3% (95% CI, 92.6 to 99.0) according to the perprotocol analysis.”Confidence interval CI 置信區間Intention-to-treat analysis 意向治療分析Perprotocol analysis 符合方案數據分析“Over the course of two epidemic seas
7、ons, the vaccine efficacy was 97.4% (95% confidence interval CI, 92.9 to 99.0) according to the intention-to-treat analysis and 97.3% (95% CI, 92.6 to 99.0) according to the perprotocol analysis.”Confidence interval CI 置信區間Intention-to-treat analysis 意向治療分析Perprotocol analysis 符合方案數據分析“Over the cour
8、se of two epidemic seasons, the vaccine efficacy was 97.4% (95% confidence interval CI, 92.9 to 99.0) according to the intention-to-treat analysis and 97.3% (95% CI, 92.6 to 99.0) according to the perprotocol analysis.”Confidence interval CI 置信區間Intention-to-treat analysis 意向治療分析Perprotocol analysis
9、 符合方案數據分析名詞、形容詞詞根201201036于怡蓓后綴-icPertaining to ?1. 加綴在名詞后面構成形容詞,表示of(與.有關的),having the nature of (有.性質的),being(是.的);made up of (由.組成的);made or caused by (由.引起的);like (像.的)。2. 表示an art or system of thought(藝術,學術),或者 a person connected with (與.有關的人)。順便指出,當-ic 充當名詞后綴時,對應的形容詞往往由-ical結尾。epidemic:epidemi
10、(流行病) + ic epidemi encephalitis 流行性乙型腦炎Epidemics of hand, foot, and mouth disease in children have emerged recently in Asia which typically show two peak epidemic incidenceseach yearIncidence:發生率,流行性的發生率 / 流行病發生率pandemic:pandem(傳染病)+ic 名詞:流行性疾病 形容詞:全國流行的the vaccine was prepared from an EV71 strain o
11、f genotype C4 isolated during a pandemic.后綴-ance :抽象名詞后綴,表示狀態、情況、性質、行為a suffix used to form nouns either from adjectives in -ant or from verbs- surveillance:surveil(監視,監測)+ ance = 監測(名詞)A health care centerbased surveillance system was set up to facilitate case-finding efforts.- significance:意義,重要性,
12、顯著性Although statistical significance was not reached 數據顯著性lost to follow-upa total of 514 participants in the vaccine group and 498 in the placebo group missed the second dose, had a protocol violation, or were lost to follow-up.-be lost to : 不再屬于所有,對無動于衷-follow-up:后續的;增補的(形容詞) 隨訪;跟進;后續行動(名詞) 失去后續跟進
13、詞例補充郭智瑋 201201050Solicitvt.& vi.征求; 懇求; 提起reports of the local and systemic reactions were solicited and recorded daily on diary cardsAny other symptoms or signs were recorded as unsolicited symptoms or signs.unsolicited adj.未被懇求的,主動提供的SolicitTo seek to obtain by persuasion, entreaty, or formal appl
14、ication 以勸說、懇求或申請的方式獲得These unsolicited adverse events were reported either spontaneously or when subjects were questioned about any changes in their health post-vaccination.A 15-day follow-up period will be observed for general symptoms solicited in the study (fever, fussiness/irritability, diarrhe
15、a, vomiting, loss of appetite and cough/runny nose). A 43-day follow-up will be observed for other unsolicited symptoms/ct/gui/show/NCT00134732Solicitsolicited symptoms研究者會對藥物的不良反應進行估計確定出一個可能常常出現的癥狀的清單在試驗的隨訪中,可以直接詢問日記卡記錄試驗日記unsolicited symptoms在solicited symptoms之外主動訴說癥狀一般未考慮到的、少見的不良事件SolicitSolicit
16、ed or unsolicited adverse events 征集性或非征集性不良反應The safety observation included close monitoring for immediate adverse events after each injection, and reports of the local and systemic reactions were solicited and recorded daily on diary cards until 7 days after each injection (see the Supplementary A
17、ppendix). Any other symptoms or signs occurring during a 28-day follow-up period after each injection were recorded as unsolicited symptoms or signs.安全觀察包括密切檢測每次注射后立即產生的不良反應,注射后7日內需每日詢問可能出現的局部不良反應和全身不良反應報告,并作為征集性不良反應記錄在日記卡上(詳見附錄)。注射28日后的隨訪期中出現的任何其他癥狀或體征將作為非征集性不良反應進行記錄Withdrawal移開; 撤回,撤退,撤開; 收回,取回,撤回
18、;The withdrawal rate was 8.4% 498 in the placebo group missed the second dose, had a protocol violation, or were lost to follow-up.withdrawal rate 醫 拉速WithdrawalThe withdrawal of something is the act or process of removing it, or ending it 撤回、結束某項事情的動作或過程The median treatment duration of 2.8 and 4.0
19、months was longer with sorafenib/placebo, which reflected the percentage of patients withdrawing after completing one or fewer treatment cycles; the withdrawal rate was 34.0% in the sorafenib/erlotinib arm compared with 23.8% with sorefenib/placebo.Withdrawalcochrane handbookWithdrawalWithdrawal 脫落
20、drop-out病人自行退出(療效太差,不良反應等)失訪研究者令其退出(依從性差,嚴重合并癥和并發癥,嚴重不良事件)雖然完成試驗,但服藥量不在應服量的80%-120%范圍內泄盲或緊急揭盲的病例Withdrawalwithdrawal rate 脫落率,退出率From March 2012 through February 2013, all the participants were monitored for hand, foot, and mouth disease after receipt of the study agent. The withdrawal rate was 8.4%
21、; a total of 514 participants in the vaccine group and 498 in the placebo group missed the second dose, had a protocol violation, or were lost to follow-up. After the exclusion of 5 children in the vaccine group and 3 in the placebo group who did not meet the age criteria, 5481 children in the vacci
22、ne group and 5499 in the placebo group were included in the per-protocol analysis.再談翻譯技巧劉曼歌201201072英語的時間地點狀語一般在句尾Epidemics of hand, foot, and mouth disease in children have emerged recently in Asia.漢語一般時間狀語在最前,之后為地點狀語,最后是句子的主體最近,亞洲出現了手足口病疫情。 The level of EV71-specific neutralizing antibodies was measured in serum samples by means of a microneutralization assay on Vero cells grown in 96-well plates with the use of a standard viral s
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 公司寵物社團活動方案
- 2025至2030年中國風電工程船行業投資策略探討及市場規模預測報告
- 2025至2030年中國非道路用柴油發動機行業全景調研及競爭格局預測報告
- 2025至2030年中國防脫生發行業供需態勢分析及投資機會分析報告
- 2025至2030年中國鍛壓機械設備行業市場需求分析及未來前景規劃報告
- 2025至2030年中國鉗形電流表行業運營現狀及投資前景展望報告
- 2025至2030年中國裂隙燈顯微鏡行業市場調查研究及未來趨勢預測報告
- 魯迅的童年教學課件
- 服務標兵面試題及答案
- 2024-2025學年下學期期末備考高二物理專題03 光學(優練)
- 個人債務結清協議書模板
- 招投標管理招聘筆試題與參考答案
- 中考化學專題:質量守恒教學設計 人教版
- 2023年全國職業院校技能大賽-融媒體內容策劃與制作賽項規程
- 國家開放大學本科《商務英語4》一平臺機考真題及答案(第一套)
- 新能源汽車動力蓄電池及管理技術 課件 模塊二 動力蓄電池管理系統功能和技術認知
- 無犯罪查詢授權委托書
- 屋頂分布式光伏電站施工管理要點
- 村霸舉報信范文(篇一)
- 《中國心力衰竭診斷和治療指南2024》解讀(總)
- 廣東省珠海市金灣區2023-2024學年七年級下學期期末考試生物試題(無答案)
評論
0/150
提交評論